Statins and Risk of Myocardial Infarction in Real Life in France

The main objective of this case-referent study is to assess the impact of statins usage on the risk of having a first myocardial infarction (MI) in a real life situation in France

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Myocardial Infarction Cardiovascular Diseases Heart Diseases Infarction Ischemia Myocardial Ischemia Necrosis Pathologic Processes Pathological Conditions, Signs and Symptoms Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Ambilly, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients can speak French or English
Patients can be interviewed by telephone
Place of usual residence in the area of recruitment

Exclusion criteria

Patients refusing to participate in the study
Patients who cannot be reached by telephone
Previous history of myocardial infarction

Treatment and study plan

Primary outcomes

Assess the impact of the different statins (molecules) usage on the risk of having a first myocardial infarction in a real life situation in France

Time frame: in 2011

Secondary outcomes

Assess the interaction between statin treatment and risk factors such as cholesterol, age, gender, tobacco, alcohol, co-prescriptions, co-morbidities

Time frame: in 2011
Assess the populational impact of statins usage on the risk of having a first myocardial infarction

Time frame: in 2011
Assess the risk of having a first myocardial infarction according to high and low dosages of statins

Time frame: in 2011

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Important dates

Study start: 2007
Primary completion: 2010
Study completion: 2010
First posted: May 19, 2008
Registry last updated: Dec 8, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed